from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0654/-

LFCtreatmentdescriptionclass of inhibitor

1.101

Amikacinug/mL Amikacintranslation

1.758

Cap5-10ug/mL Capreomycintranslation

1.908

Rox10-50 ug/mL Roxithromycintranslation

0.303

SM2-5 ug/mL Streptomycintranslation

2.198

Tet5-10 ug/mL Tetracyclinetranslation

-0.803

Rif0.2-5ug/mL Rifampicintranscription

-0.463

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.505

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.531

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.368

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.800

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.672

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.666

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.041

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.430

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.541

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.367

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.555

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.968

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.289

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.012

KCN5-20 ug/mL Potassium cyaniderespiration

-0.239

NaN30.2-2 mM Sodium aziderespiration

0.097

Nigericin50 uM Nigericinrespiration

-0.167

TRC10-150 ug/mL Triclosanrespiration

1.300

TRZ10-25 ug/mL Thioridazinerespiration

0.270

Valinomycin0.5-10 uM Valinomycinrespiration

-2.040

ZnSO42 mM ZnSO4respiration

0.134

menadione6-10 ug/mL Menadionerespiration

-0.005

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.549

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.342

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.406

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.234

NRP_1Non-replicating persistence stage 1dosRassociated

-0.599

Amp0.2mg/mL AmpicillincellWall

-0.277

Cephalexin20-100 ug/mL CephalexincellWall

-0.605

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.639

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.662

EMB10-20 ug/mL EthambutolcellWall

-0.388

Eta12-40 ug/mL EthionamidecellWall

-0.406

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.352

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.464

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.765

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.457

BZA0.12 mg/mL BenzamidearomaticAmides

0.163

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.873

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.056

H2O24 mM hydrogen peroxideDNAdamaging

-0.413

Levo10 ug/mL LevofloxacinDNAdamaging

-0.249

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.230

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.387

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.346

UVUV-irradiationDNAdamaging

3.390

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.315

Antimycin12.5-50 ug/mL Antimycin A?

-0.433

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.193

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.085

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.291

PA8240.2-2 ug/mL PA-824?

0.973

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.068

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.556

Verapamil50 uM Verapamil?

-0.518

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.468

methoxatin10-20 ug/mL Methoxatin?